# Patient insights research exploring disease awareness, patient life experience, and current management of visceral leishmaniasis in Bihar, India

**Authors:** Shyam Sundar, Fabiana Alves, Koert Ritmeijer, Margriet den Boer, Colin Forsyth, Bethan Hughes, Clare Zamble, Kirsten Carter, Gerhild Angyalosi

PMC · DOI: 10.1371/journal.pntd.0012326 · PLOS Neglected Tropical Diseases · 2025-02-25

## TL;DR

This study explores the challenges faced by patients and caregivers of children with visceral leishmaniasis in Bihar, India, highlighting barriers to care and interest in oral treatments.

## Contribution

The study provides patient-centric insights into the lived experience of visceral leishmaniasis in rural India, emphasizing unmet needs and potential gaps in public health access.

## Key findings

- Patients often face delayed diagnosis and treatment due to limited healthcare urgency and access.
- Most patients prefer an oral treatment option for VL to reduce travel and financial burdens.
- Caregivers and patients reported significant out-of-pocket costs and time away from work or home duties.

## Abstract

Visceral leishmaniasis (VL) is a vector-borne disease caused by Leishmania parasites and transmitted by sand fly bites, targeted for elimination in India. VL primarily affects rural, low-income populations with limited health care access. In South Asia, few studies have explored patients’ perspectives, diagnoses, and treatment experiences; particularly lacking an understanding about the patients’ life experiences outside of clinical research settings.

A qualitative study was conducted in Bihar, India, using moderator-facilitated, protocol-defined discussion. Eighteen adult patients and 12 caregivers of children diagnosed with and treated for VL within the last 12 months were identified by self-report. Mean time from symptom onset to diagnosis was 13.8 days. Challenges of the early patient life experience included lack of urgency by health care professionals, delayed diagnosis, and no guarantee of treatment at the location of their VL diagnosis (63% had to switch to a different center for treatment, at times delaying treatment). Key barriers identified in previous studies that were re-confirmed in this study include out-of-pocket financial burden, absence from work/home duties, and long-distance travel to hospitals. Patients and caregivers (n = 29/30) expressed a preference for a potential oral treatment that could be taken close to home.

This study reveals new insights about the patient life experience and reconfirms previous research indicating that access to care for patients with VL in the Bihar area remains a challenge. Although most patients with VL seek care early, diagnosis often requires multiple visits to a health care facility. Despite access to therapy in public hospitals, some patients reported a preference for private care. Even if diagnosis takes place in a government-funded public setting, some patients reported needing to move from the location of diagnosis to another center to receive therapy, creating an additional burden for patients. As a potential alternative to current parenteral treatment, adult patients and caregivers of pediatric patients expressed interest in a potential oral therapy because it may reduce barriers to access care.

This is an interview-based investigation of patient awareness, experience, and individual challenges for adults and caregivers of children seeking diagnosis and effective care for visceral leishmaniasis (VL) in rural districts of Bihar, India. Patients’ descriptions of their health experiences revealed obstacles at every stage, including limited information about the illness at the community level, financial burdens associated with loss of work, and cost of travel to seek diagnosis. Although our study was subject to recall bias, it elicited insights from the patients’ own experiences and revealed deterrents and burdens that may not have been visible otherwise. Our study also explored patient and caregiver interest in a potential oral treatment for VL. This patient-centric approach of identifying unmet needs and potential gaps in public health access could be useful in furthering the aims of the National Elimination Program for VL in India and in other areas with endemic VL, particularly those planning to introduce elimination programs.

## Linked entities

- **Diseases:** visceral leishmaniasis (MONDO:0005445), VL (MONDO:0024555)
- **Species:** Leishmania (taxon 5658)

## Full-text entities

- **Diseases:** VL (MESH:D007898), Leishmania parasites (MESH:D007896), vector-borne disease (MESH:D000079426)
- **Species:** Drosophila melanogaster (fruit fly, species) [taxon 7227], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11856310/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11856310/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC11856310/full.md

---
Source: https://tomesphere.com/paper/PMC11856310